FundedIQ
Biotechnology

Seneca Therapeutics: Funding, Investors & Team (Nov 2026)

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.

senecatherapeutics.com LinkedIn Blue Bell, United States 11-50 employees
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Total raised
$11.6M
Rounds
2
Latest
Series B
Aug 2025

Seneca Therapeutics has raised $11.6M across 2 funding rounds on record, the most recent a Series B of $3.9M announced in Aug 2025.

That round is below the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Seneca Therapeutics Company Profile and Key Stats

Total funding raised
$11.6M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$3.9M in Aug 2025
Employees
11-50
reported band
Headquarters
Blue Bell, United States

Latest funding round on record: Aug 2025.

Seneca Therapeutics Funding Rounds

Date
Round
Amount
Series B
$3.9M
Undisclosed round
$7.7M

Seneca Therapeutics raised $7.7M in an undisclosed round announced in Jan 2023.

2.6 years later, a Series B of $3.9M was announced in Aug 2025.

Seneca Therapeutics Founders and Leadership Team

Name
Role
Contact
Paul Hallenbeck
Founder
Locked

Contact details for the Seneca Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Seneca Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.8M
30,541
$7.8M
4,467
$31M

Seneca Therapeutics' latest round of $3.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Seneca Therapeutics in Biotechnology and Blue Bell

Companies Similar to Seneca Therapeutics

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Seneca Therapeutics Funding FAQs

What does Seneca Therapeutics do?

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.

How much funding has Seneca Therapeutics raised?

Seneca Therapeutics has raised $11.6M across 2 rounds on record. The most recent is a Series B of $3.9M announced in Aug 2025.

When did Seneca Therapeutics last raise funding?

Seneca Therapeutics' most recent funding round on record is a Series B of $3.9M, announced in Aug 2025.

Who founded Seneca Therapeutics?

FundedIQ lists Paul Hallenbeck (Founder) at Seneca Therapeutics.

Where is Seneca Therapeutics headquartered?

Seneca Therapeutics is based in Blue Bell, Pennsylvania, United States.

How many employees does Seneca Therapeutics have?

Seneca Therapeutics is in the 11-50 employee band.

How does Seneca Therapeutics' funding compare to other Biotechnology startups?

Seneca Therapeutics' latest round of $3.9M is below the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Seneca Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seneca Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.